This model
offers unique capabilities for
preclinical assessment of thrombosis risk in a patient - specific manner, including efficacy
testing of anti-thrombotic agents, elucidation of mechanism of action, and, potentially, biomarker identification, all providing a much - needed platform for drug discovery and development.